COMMON MAPS
Map version new-york activity top-down
MCP Main site Contact
Menu
·
research dossier

ELEVAATE BIOTECH INC

NEW YORK, NY · EIN 994359759 · Form 990 · FY2024 · NTEE S99 · Community Improvement · Small ($100K-$1M) · elevaate.org
revenue
$475K
expenses
$161K
net assets
$314K
employees
1
volunteers
12
program ratio
45%
mission · from form 990

DEDICATED TO FURTHERING EAST ASIAN AMERICAN LEADERSHIP OF THE BIOTECH AND PHARMACEUTICAL INDUSTRIES

profile · synthesized from sources

ElevAAte Biotech is a nonprofit focused on advancing East Asian American leadership within the biotechnology and pharmaceutical industries. The organization strengthens networks among mid- and senior-career professionals, supports leadership development, and promotes public narratives highlighting East Asian American contributions. It operates nationally with a mission rooted in community building, mentorship, and industry awareness.

named programs · 3 · from sources

What they call their work

Community Networks
Initiative to strengthen professional networks among mid- and senior-career East Asian Americans in biotechnology and pharmaceuticals.
Leadership Development
Program to mentor and train rising East Asian American executives in the biopharma industry, empowering current leaders through networking and skill-building opportunities.
Media Engagement and Narrative Building
Effort to highlight East Asian American leadership through media training and public storytelling, including events like "Working with the Media (Even if You'd Rather Not)" and the 2025 Report.
activities · 1 group

What they do

  • Uncategorized 1 activity
    • Advancing East Asian American leadership in biotech and pharmaceutical industries
      Conducts research and implements capacity-building initiatives aimed at strengthening East Asian American leadership within the biotech and pharmaceutical sectors. Published a report in 2025 detailing findings on this focus area.
financials · form 990 · fy2024
revenue
Total revenue$475K
Contributions & grants$475K100%
Program service revenue$00%
Investment income$360%
Other revenue$0
expenses
Total expenses$161K
Program expenses45%
Admin / overhead50%
Fundraising5%
Salaries & benefits$104K
Grants paid out$0
Largest expense lineCompensation
balance sheet
Total assets$345K
Cash$283K
Investments$0
Liabilities$31K
Net assets$314K
Liquid reserves21.1 mo
1 years on record · 2024–2024
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 1
NameTitleHours/wkCompensation
ELAINE CHEN EXECUTIVE DIRECTOR 40 $92K
board members · 7
  • ANGIE YOU — TREASURER
  • BONG KOH — BOARD MEMBER
  • CHEN YU — SECRETARY
  • JUNE LEE — CHAIR
  • KEN SONG — BOARD MEMBER
  • LORENCE KIM — BOARD MEMBER
  • MATT KIM — BOARD MEMBER
relationships · 2

Who they work with

  • BioPharma Dive Partner — Collaborated with BioPharma Dive journalists to provide insights on media engagement for biotech leaders.
  • Endpoints News Partner — Collaborated with Endpoints News journalists to provide insights on media engagement for biotech leaders.
strategies · 3

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.